Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122879675 | 12287967 | 5 | F | 20160407 | 20160811 | 20160420 | 20160818 | PER | US-ACTELION PHARMACEUTICALS US, INC.-A-US2016-134865 | ACTELION | 52.00 | YR | A | F | Y | 0.00000 | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122879675 | 12287967 | 1 | PS | OPSUMIT | MACITENTAN | 1 | Oral | 10 MG, QD | 204410 | 10 | MG | TABLET | QD | ||||||
| 122879675 | 12287967 | 2 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 1600 MCG, BID | N | 207947 | 1600 | UG | TABLET | BID | |||||
| 122879675 | 12287967 | 3 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | UNK | N | 207947 | TABLET | ||||||||
| 122879675 | 12287967 | 4 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 800 MCG, BID | N | 207947 | 800 | UG | TABLET | BID | |||||
| 122879675 | 12287967 | 5 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | UNK | U | 21779 | INHALATION VAPOUR, SOLUTION | ||||||||
| 122879675 | 12287967 | 6 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | U | 0 | |||||||||||
| 122879675 | 12287967 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 | |||||||||||
| 122879675 | 12287967 | 8 | C | IRON | IRON | 1 | U | 0 | |||||||||||
| 122879675 | 12287967 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | U | 0 | |||||||||||
| 122879675 | 12287967 | 10 | C | GLUCOSAMINE | GLUCOSAMINE | 1 | U | 0 | |||||||||||
| 122879675 | 12287967 | 11 | C | GUAIFENESIN AND CODEINE PHOSPHATE | CODEINE PHOSPHATEGUAIFENESIN | 1 | U | 0 | |||||||||||
| 122879675 | 12287967 | 12 | C | ANUSOL NOS | BALSAM PERUBENZYL BENZOATEBISMUTH HYDROXIDEBISMUTH SUBGALLATEHYDROCORTISONE ACETATEINC OXIDE | 1 | U | 0 | |||||||||||
| 122879675 | 12287967 | 13 | C | LORAZEPAM. | LORAZEPAM | 1 | U | 0 | |||||||||||
| 122879675 | 12287967 | 14 | C | SULINDAC. | SULINDAC | 1 | U | 0 | |||||||||||
| 122879675 | 12287967 | 15 | C | TRIAMCINOLONE | TRIAMCINOLONE | 1 | U | 0 | |||||||||||
| 122879675 | 12287967 | 16 | C | ADCIRCA | TADALAFIL | 1 | U | 0 | |||||||||||
| 122879675 | 12287967 | 17 | C | HYDROCODONE | HYDROCODONE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122879675 | 12287967 | 1 | Pulmonary arterial hypertension |
| 122879675 | 12287967 | 2 | Pulmonary arterial hypertension |
| 122879675 | 12287967 | 5 | Pulmonary arterial hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122879675 | 12287967 | Condition aggravated | |
| 122879675 | 12287967 | Headache | |
| 122879675 | 12287967 | Myalgia | |
| 122879675 | 12287967 | Pain | |
| 122879675 | 12287967 | Pain in extremity | |
| 122879675 | 12287967 | Pain in jaw |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122879675 | 12287967 | 1 | 20151021 | 0 | ||
| 122879675 | 12287967 | 3 | 20160429 | 0 | ||
| 122879675 | 12287967 | 5 | 20151119 | 0 |